These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22772471)

  • 1. Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.
    Winston A; Duncombe C; Li PC; Gill JM; Kerr SJ; Puls RL; Taylor-Robinson SD; Emery S; Cooper DA;
    Neuroradiology; 2012 Dec; 54(12):1331-9. PubMed ID: 22772471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
    Bladowska J; Zimny A; Kołtowska A; Szewczyk P; Knysz B; Gąsiorowski J; Furdal M; Sąsiadek MJ
    Eur J Radiol; 2013 Apr; 82(4):686-92. PubMed ID: 23246331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study.
    Winston A; Duncombe C; Li PC; Gill JM; Kerr SJ; Puls R; Petoumenos K; Taylor-Robinson SD; Emery S; Cooper DA;
    Clin Infect Dis; 2010 Mar; 50(6):920-9. PubMed ID: 20146627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
    Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
    Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naïve HIV patients.
    Chang L; Ernst T; Witt MD; Ames N; Gaiefsky M; Miller E
    Neuroimage; 2002 Nov; 17(3):1638-48. PubMed ID: 12414302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.
    Gongvatana A; Harezlak J; Buchthal S; Daar E; Schifitto G; Campbell T; Taylor M; Singer E; Algers J; Zhong J; Brown M; McMahon D; So YT; Mi D; Heaton R; Robertson K; Yiannoutsos C; Cohen RA; Navia B;
    J Neurovirol; 2013 Jun; 19(3):209-18. PubMed ID: 23613008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART.
    Harezlak J; Cohen R; Gongvatana A; Taylor M; Buchthal S; Schifitto G; Zhong J; Daar ES; Alger JR; Brown M; Singer EJ; Campbell TB; McMahon D; So YT; Yiannoutsos CT; Navia BA;
    J Neurovirol; 2014 Jun; 20(3):294-303. PubMed ID: 24696364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children.
    Van Dalen YW; Blokhuis C; Cohen S; Ter Stege JA; Teunissen CE; Kuhle J; Kootstra NA; Scherpbier HJ; Kuijpers TW; Reiss P; Majoie CBLM; Caan MWA; Pajkrt D
    Medicine (Baltimore); 2016 Mar; 95(12):e3093. PubMed ID: 27015179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy and its influence on the stage of brain damage in patients with HIV - 1H MRS evaluation.
    Tarasów E; Wiercińska-Drapało A; Jaroszewicz J; Orzechowska-Bobkiewicz A; Dzienis W; Prokopowicz D; Walecki J
    Med Sci Monit; 2004 Jun; 10 Suppl 3():101-6. PubMed ID: 16538209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the direction of change of cerebral function parameters are evident over three years in HIV-infected individuals electively commencing initial cART.
    Winston A; Puls R; Kerr SJ; Duncombe C; Li P; Gill JM; Ramautarsing R; Taylor-Robinson SD; Emery S; Cooper DA;
    PLoS One; 2015; 10(2):e0118608. PubMed ID: 25723494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts.
    Vigneswaran S; Rojas JH; Garvey L; Taylor-Robinson S; Winston A
    Neuroradiol J; 2015 Dec; 28(6):545-54. PubMed ID: 26493269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia.
    Chang L; Ernst T; Leonido-Yee M; Witt M; Speck O; Walot I; Miller EN
    Neurology; 1999 Sep; 53(4):782-9. PubMed ID: 10489041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis.
    Lee PL; Yiannoutsos CT; Ernst T; Chang L; Marra CM; Jarvik JG; Richards TL; Kwok EW; Kolson DL; Simpson D; Tang CY; Schifitto G; Ketonen LM; Meyerhoff DJ; Lenkinski RE; Gonzalez RG; Navia BA;
    J Magn Reson Imaging; 2003 Jun; 17(6):625-33. PubMed ID: 12766890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy.
    Sailasuta N; Ananworanich J; Lerdlum S; Sithinamsuwan P; Fletcher JL; Tipsuk S; Pothisri M; Jadwattanakul T; Jirajariyavej S; Chalermchai T; Catella S; Busovaca E; Desai A; Paul R; Valcour V;
    J Acquir Immune Defic Syndr; 2016 Jan; 71(1):24-30. PubMed ID: 26258565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered neurometabolite development in HIV-infected children: correlation with neuropsychological tests.
    Keller MA; Venkatraman TN; Thomas A; Deveikis A; LoPresti C; Hayes J; Berman N; Walot I; Padilla S; Johnston-Jones J; Ernst T; Chang L
    Neurology; 2004 May; 62(10):1810-7. PubMed ID: 15159483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurometabolic Remodeling in Chronic Hiv Infection: a Five-Year Follow-up Multi-Voxel Mrs Study.
    Boban J; Thurnher MM; Brkic S; Lendak D; Bugarski Ignjatovic V; Todorovic A; Kozic D
    Sci Rep; 2019 Dec; 9(1):19799. PubMed ID: 31875001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease.
    Anderson AM; Fennema-Notestine C; Umlauf A; Taylor MJ; Clifford DB; Marra CM; Collier AC; Gelman BB; McArthur JC; McCutchan JA; Simpson DM; Morgello S; Grant I; Letendre SL;
    J Neurovirol; 2015 Oct; 21(5):559-67. PubMed ID: 26069183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing multiple-group diagnostic problems with multi-dimensional receiver operating characteristic surfaces: application to proton MR Spectroscopy (MRS) in HIV-related neurological injury.
    Yiannoutsos CT; Nakas CT; Navia BA;
    Neuroimage; 2008 Mar; 40(1):248-55. PubMed ID: 18191586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral metabolic alterations in human immunodeficiency virus-related encephalopathy detected by proton magnetic resonance spectroscopy. Comparison between sequences using short and long echo times.
    Salvan AM; Vion-Dury J; Confort-Gouny S; Nicoli F; Lamoureux S; Cozzone PJ
    Invest Radiol; 1997 Aug; 32(8):485-95. PubMed ID: 9258737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS.
    Fuller RA; Westmoreland SV; Ratai E; Greco JB; Kim JP; Lentz MR; He J; Sehgal PK; Masliah E; Halpern E; Lackner AA; González RG
    BMC Neurosci; 2004 Mar; 5():10. PubMed ID: 15070430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.